Form 4 for ALZN Alzamend Neuro, Inc.
Accepted 2021-10-18 00:00:00 ET · period of report 2021-10-15 · accession 0001214659-21-010561 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-18 | 2021-10-15 | ALZN | McGrath Lynne Fahey | Dir | M - OptEx | $0.00 | +47.2K | 50.0K | +1,700% | $0 |
| D | 2021-10-18 | 2021-10-15 | ALZN | McGrath Lynne Fahey | Dir | M - OptEx | $0.00 | -47.2K | 50.0K | -49% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-15 | M | A | 47,222 | $0.00 | 50,000 | D | — | — | |
| 2 | Derivative | Restricted Stock Grant | 2021-10-15 | M | D | 47,222 | $0.00 | 50,000 | D | — · — to 2022-03-15 | 47,222 Common Stock | (F2) Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc. (F3) The restricted stock grant was amended on October 13, 2021, such that 47,222 shares of restricted stock vested on October 15, 2021, and the remaining 50,000 shares of restricted stock shall vest on March 15, 2022. 2,778 shares previously vested on September 13, 2021. |